US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist
  • 0.669
  • 0.0000.00%
Close Jul 22 16:00 ET
16.78MMarket Cap-552P/E (TTM)

Sensei Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.69%8.73M
-26.15%37.06M
-37.60%8.14M
-44.50%7.74M
-4.99%10.18M
-11.84%11.01M
33.90%50.19M
38.62%13.05M
35.14%13.94M
9.48%10.71M
Selling and administrative expenses
-34.30%3.81M
-5.25%18.77M
-36.02%3.65M
-17.51%3.92M
24.87%5.39M
15.34%5.8M
25.19%19.81M
64.97%5.7M
22.67%4.75M
11.14%4.32M
-General and administrative expense
-34.30%3.81M
-5.25%18.77M
-36.02%3.65M
-17.51%3.92M
24.87%5.39M
15.34%5.8M
25.19%19.81M
64.97%5.7M
22.67%4.75M
11.14%4.32M
Research and development costs
-5.51%4.92M
-39.77%18.3M
-38.83%4.49M
-58.45%3.82M
-25.17%4.78M
-30.19%5.2M
40.26%30.38M
23.32%7.35M
42.64%9.19M
8.39%6.39M
Operating profit
20.69%-8.73M
26.15%-37.06M
37.60%-8.14M
44.50%-7.74M
4.99%-10.18M
11.84%-11.01M
-33.90%-50.19M
-38.62%-13.05M
-35.14%-13.94M
-9.48%-10.71M
Net non-operating interest income expense
-20.17%740K
122.51%3.48M
-2.45%795K
67.13%844K
416.38%914K
1,283.58%927K
1,103.08%1.56M
2,810.71%815K
689.06%505K
331.71%177K
Non-operating interest income
-20.74%768K
103.25%3.62M
35.63%826K
70.29%877K
172.78%952K
212.58%969K
122.88%1.78M
82.34%609K
85.25%515K
85.64%349K
Non-operating interest expense
-33.33%28K
-34.25%144K
115.05%31K
230.00%33K
-77.91%38K
-82.72%42K
-67.31%219K
-167.32%-206K
-95.33%10K
17.01%172K
Other net income (expense)
97.92%-2K
-1,536.11%-517K
-6,800.00%-67K
-1,255.00%-231K
-123K
-740.00%-96K
-93.55%36K
-94.74%1K
-96.47%20K
Special income (charges)
--0
---302K
--0
---6K
---191K
---105K
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
--0
---302K
--0
---6K
---191K
---105K
--0
--0
--0
--0
Other non- operating income (expenses)
-122.22%-2K
-697.22%-215K
-6,800.00%-67K
-1,225.00%-225K
--68K
-40.00%9K
500.00%36K
-94.74%1K
--20K
----
Income before tax
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
-7.82%-10.54M
Income tax
Net income
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
-7.82%-10.54M
Net income continuous Operations
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
-7.82%-10.54M
Minority interest income
Net income attributable to the parent company
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
-7.82%-10.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
-7.82%-10.54M
Basic earnings per share
3.03%-0.32
22.78%-1.22
25.00%-0.3
36.36%-0.28
8.82%-0.31
17.50%-0.33
-18.80%-1.58
-33.33%-0.4
-37.50%-0.44
-6.25%-0.34
Diluted earnings per share
3.03%-0.32
22.78%-1.22
25.00%-0.3
36.36%-0.28
8.82%-0.31
17.50%-0.33
-18.80%-1.58
-33.33%-0.4
-37.50%-0.44
-6.25%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.69%8.73M-26.15%37.06M-37.60%8.14M-44.50%7.74M-4.99%10.18M-11.84%11.01M33.90%50.19M38.62%13.05M35.14%13.94M9.48%10.71M
Selling and administrative expenses -34.30%3.81M-5.25%18.77M-36.02%3.65M-17.51%3.92M24.87%5.39M15.34%5.8M25.19%19.81M64.97%5.7M22.67%4.75M11.14%4.32M
-General and administrative expense -34.30%3.81M-5.25%18.77M-36.02%3.65M-17.51%3.92M24.87%5.39M15.34%5.8M25.19%19.81M64.97%5.7M22.67%4.75M11.14%4.32M
Research and development costs -5.51%4.92M-39.77%18.3M-38.83%4.49M-58.45%3.82M-25.17%4.78M-30.19%5.2M40.26%30.38M23.32%7.35M42.64%9.19M8.39%6.39M
Operating profit 20.69%-8.73M26.15%-37.06M37.60%-8.14M44.50%-7.74M4.99%-10.18M11.84%-11.01M-33.90%-50.19M-38.62%-13.05M-35.14%-13.94M-9.48%-10.71M
Net non-operating interest income expense -20.17%740K122.51%3.48M-2.45%795K67.13%844K416.38%914K1,283.58%927K1,103.08%1.56M2,810.71%815K689.06%505K331.71%177K
Non-operating interest income -20.74%768K103.25%3.62M35.63%826K70.29%877K172.78%952K212.58%969K122.88%1.78M82.34%609K85.25%515K85.64%349K
Non-operating interest expense -33.33%28K-34.25%144K115.05%31K230.00%33K-77.91%38K-82.72%42K-67.31%219K-167.32%-206K-95.33%10K17.01%172K
Other net income (expense) 97.92%-2K-1,536.11%-517K-6,800.00%-67K-1,255.00%-231K-123K-740.00%-96K-93.55%36K-94.74%1K-96.47%20K
Special income (charges) --0---302K--0---6K---191K---105K--0--0--0--0
-Gain on sale of property,plant,equipment --0---302K--0---6K---191K---105K--0--0--0--0
Other non- operating income (expenses) -122.22%-2K-697.22%-215K-6,800.00%-67K-1,225.00%-225K--68K-40.00%9K500.00%36K-94.74%1K--20K----
Income before tax 21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M-7.82%-10.54M
Income tax
Net income 21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M-7.82%-10.54M
Net income continuous Operations 21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M-7.82%-10.54M
Minority interest income
Net income attributable to the parent company 21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M-7.82%-10.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M-7.82%-10.54M
Basic earnings per share 3.03%-0.3222.78%-1.2225.00%-0.336.36%-0.288.82%-0.3117.50%-0.33-18.80%-1.58-33.33%-0.4-37.50%-0.44-6.25%-0.34
Diluted earnings per share 3.03%-0.3222.78%-1.2225.00%-0.336.36%-0.288.82%-0.3117.50%-0.33-18.80%-1.58-33.33%-0.4-37.50%-0.44-6.25%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg